Scientists Just Won The Nobel Prize For Inventing A Switch That Turns Individual Brain Cells On And Off
The Nobel Assembly at Karolinska Institutet awarded the 2026 Nobel Prize in Physiology or Medicine jointly to Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University of Berlin, and Georg Nagel of the University of Würzburg, for discoveries that gave neuroscientists the ability to do something that was previously impossible: turn individual brain cells on or off at will, using pulses of light, in a living brain. The technique is called optogenetics, and it works by inserting genes for light-sensitive proteins called channelrhodopsins, discovered in algae, directly into specific neurons. When light is then delivered to those neurons through a thin optical fiber threaded into the brain, the targeted cells activate or deactivate in milliseconds, with a precision that electrodes and drugs cannot match. The story begins with the algae. Hegemann and Nagel identified and characterized channelrhodopsins, proteins that the algae use to steer toward or away from light, and proved that these proteins could function as ion channels controllable by light pulses. Deisseroth, a psychiatrist and bioengineering professor at Stanford, took their discovery and made it work inside living mammalian neurons in 2005, publishing the first demonstration of optogenetics in the journal Nature Neuroscience. Within two years his laboratory had used the technique in living mice, controlling the activity of specific neurons in real time and directly observing how those neurons shaped behavior.
The impact on neuroscience has been described by the Nobel Committee as fundamental. Before optogenetics, researchers studying the brain could observe neural activity or disrupt it broadly, but they could not activate or silence specific neurons in specific circuits with the precision needed to untangle which cells are doing which jobs. Optogenetics gave them a switch, and with that switch they have begun to decode how the brain builds memories, generates emotions, drives addiction, produces the symptoms of depression, and controls movement. Deisseroth's laboratory used the technique to identify specific neural circuits involved in depression and show that stimulating them could reverse depressive behavior in animal models, a finding that has pointed toward new potential targets for treatment-resistant depression in humans. The technique has also been used to study the neural basis of Parkinson's disease, anxiety, sleep, and social behavior, and it has been adopted in laboratories around the world as a standard tool of brain research. Deisseroth has since developed a companion technique called CLARITY, which renders brain tissue transparent and allows high-resolution imaging of the circuits optogenetics helps control. He received his neuroscience PhD and his MD from Stanford, where he is now the D.H. Chen Professor and a practicing psychiatrist who continues to see patients alongside his research. The Nobel Committee described the prize as honoring discoveries that are unraveling one of humanity's greatest mysteries: how the brain works. It started, specifically, with a protein that helps algae find light. Scientists spend a long time looking in unexpected places for the things that matter most, and sometimes they find them there.
